Pfizer and BioNTech have announced the start of a phase 1/2 study of their mRNA shingles vaccine candidates. The US-based study is aiming to enrol up to 900 healthy volunteers aged from 50 to 69 years ...

Moderna is suing Pfizer in a Massachusetts court over alleged patent infringement in the development of the first COVID-19 vaccine. mRNA vaccines deliver instructions to cells to build a harmless ...

Moderna said it's not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales. Moderna sued Pfizer and BioNTech in U.S. and German ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...